Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9652
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShah, Ananya-
dc.date.accessioned2021-01-28T11:04:29Z-
dc.date.available2021-01-28T11:04:29Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9652-
dc.descriptionGuided by Dr. Jignasa Savjanien_US
dc.description.abstractThe aim of this thesis is to review various ecotoxicological effects of pharmaceutical relevant organohalides with a focus on three: endocrine disruption, antibiotic resistance and behavioral alteration. In addition to that, it enlists the various methods used to carry out ecotoxicological studies and environmental impact assessments as guided by various regulatory agencies and intergovernmental organisations. It also throws light on the significance of studying the ecotoxicological impact of pharmaceutically relevant organohalides. It is found that this class of contaminants is most abundant in aquatic environment. So, to address the need for a treatment method for such substances in the environment, the potential of using dehalococcoides species as a biological marker and biodegradation is discussed. It emerges as the most selective technique for reduction of such contaminants in the environment. Towards the end of the thesis, several important tools and strategies are discussed to mitigate the overall impact of not just the aforementioned class of organohalides but other pharmaceutical waste in order to bring about environmental sustainability in the pharmaceutical industry.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR00936;-
dc.subjectPPR00936en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectPharmaceutical Chemistryen_US
dc.subjectEcotoxicologyen_US
dc.subjectOrganohalidesen_US
dc.subjectSustainabilityen_US
dc.subjectPharmaceutical industryen_US
dc.titleEcotoxicology of Organohalides: A Review on Effects and Mitigation for Sustainability in Pharmaceutical Industryen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR00936.pdfPPR009365.25 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.